课题基金 / 基金详情

Role of Endothelial Lipase in Atherosclerosis

Role of Endothelial Lipase in Atherosclerosis
内皮脂肪酶在动脉粥样硬化中的作用
批准号:
7048121
负责人:
HAMID RAZZAGHI
金额:
$36.34万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-15 至 2009-01-31

项目摘要

项目成果

HAMID RAZZAGHI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The leading cause of coronary heart disease (CHD) is atherosclerosis of the coronary arteries, which is one of the most prevalent causes of morbidity and mortality in man. A major predisposing factor to atherosclerosis is low levels of high density lipoprotein-cholesterol (HDL-C). About half of the variation in HDL-C levels is due to genetic influences. Recently, a newly discovered gene, called endothelial lipase (EL), has been shown to have several unique features that make EL a prime candidate gene for low HDL-C and atherosclerosis. EL affects HDL metabolism in vivo, has high levels of phospholipase activity, is expressed by vascular endothelium, and is upregulated by inflammatory cytokines. The objectives of this project are to determine the genetic contribution of EL to variation in plasma lipid profile and to assess its role structurally and functionally. To achieve these objectives, the following specific aims will be carried out. 1) To identify and characterize mutations in the exons and intron-exon boundaries of the EL gene, molecular genetic techniques will be used in selected individuals expressing the extreme phenotype of high and low HDL-C levels. The impact of the discovered mutations on plasma lipid profile will be evaluated in two population- based samples of Hispanics (n=406) and non-Hispanic Whites (n=604) using statistical methods. 2) To build and characterize a refined 3D molecular model of EL, homology modeling techniques will be used and its structural features will be characterized. Mutant 3D models will be generated for all missense mutations identified in Aim 1 and compared with the wild type model for structural differences using molecular modeling techniques. 3) To assess the lipase activity of the mutations identified in Aim 1 and structurally assessed in Aim 2, in vitro mutagenesis, expression, and functional studies will be used. In summary, this comprehensive project will characterize EL with respect to its genetic, structure, and function in regulating plasma HDL-C levels and hence a major genetic risk factor for atherosclerosis. Understanding the molecular basis of risk factors in atherosclerosis may lead to new strategies for reducing the risk of coronary heart disease in the population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Endothelial Lipase in Atherosclerosis
  • 批准号:
    7344748
  • 项目类别:
  • 资助金额:
    $37.38万
  • 财政年份:
    2006
  • 负责人:
    HAMID RAZZAGHI
  • 依托单位:
Role of Endothelial Lipase in Atherosclerosis
  • 批准号:
    7178529
  • 项目类别:
  • 资助金额:
    $37.38万
  • 财政年份:
    2006
  • 负责人:
    HAMID RAZZAGHI
  • 依托单位:
国内基金
海外基金
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
  • 批准号:
    91957111
  • 项目类别:
    重大研究计划
  • 资助金额:
    80.0万元
  • 批准年份:
    2019
  • 负责人:
    李佩盈
  • 依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 项目类别:
    面上项目
  • 资助金额:
    14.0万元
  • 批准年份:
    2011
  • 负责人:
    刘梅林
  • 依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
  • 批准号:
    81070247
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    秦树存
  • 依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
  • 批准号:
    81000086
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    江立生
  • 依托单位: